Pi Coin, Pepe, Injective Rocket 50%+ in 7 Days—Who Takes the Crown Next Week?
Crypto markets just witnessed a blistering rally—Pi Coin surged 58%, Pepe defied memecoin gravity with a 63% pump, and Injective’s DeFi protocols fueled a 49% breakout. Now traders are scrambling for the next alpha.
Will Layer 2 tokens catch fire after Ethereum’s latest upgrade? Can Solana-based memecoins ride the Pepe wave? Or is this the week AI tokens finally wake up—assuming their whitepapers weren’t written by ChatGPT?
One thing’s certain: Wall Street’s ’risk managers’ will pretend to understand the moves... right after their third espresso martini.
Pi Coin, Pepe & Injective are showing off with some of the biggest gains this week. In just 7 days, PI is up 104%, PEPE surged 73%, and INJ jumped 42%. These coins are clearly leading the way right now.
But there’s one more name heating up fast, Remittix. It’s already upfrom its presale launch, and momentum’s still building. With a red-hot presale and growing hype, Remittix might just be the next breakout star.
Pi Coin (PI): 104% Surge Steals the Spotlight
Pi Coin is on a roll right now! It’s already up 56% over the last month, but the real action is happening in the past 7 days, with an amazing 104% increase. Pi Coin is part of the Pi Network, which aims to provide a decentralized and easy-to-use digital currency for everyday users.
Source
Looking at the technical picture, PI Coin has broken out of a long accumulation phase. It’s now trading above key 10-day, 20-day, and 50-day moving averages. With all these signals flashing “buy,” Pi Coin looks set for further upside.
Pepe (PEPE): 73% Rally Shows Meme Coin Power
Pepe (PEPE) is riding high again. It’s up 87% over the last 30 days, and just in the past 7 days, it’s jumped another 73%. The trend is clear: Pepe is still climbing, gaining more traction with every move.
Source
The rally is backed by a record Open Interest (OI) of $583 million, signaling heavy action in the derivatives market. The OI-weighted funding rate sits at 0.0272%, showing strong long positions in play for PEPE. Still, with liquidations peaking at $5 million, there’s some short-term volatility risk if PEPE can’t clear its current resistance zone.
Injective (INJ): 42% Jump Reflects Growing Momentum
Injective (INJ) is on fire, jumping 63% in the past 30 days and 42% in just the last week. The momentum is strong and steady, and all signs point to more upside. With a market cap around $1.33 billion, many investors believe INJ could soon revisit its $34 high from last year.
Source
Injective is turning heads by bringing big-name stocks like $AAPL, $MSFT, $AMZN, and $NFLX onchain, joining others like $META and $TSLA on its HelixApp exchange. This isn’t just token wrapping, it’s a real shift in finance, where Wall Street meets blockchain and Injective leads the charge in the RWA revolution.
Remittix (RTX): 400% Presale Gains Fuel Growing Buzz
Remittix (RTX) is rapidly becoming the go-to altcoin for savvy investors, already holding its ground next to names like Toncoin, Sui, and Polkadot. But what sets it apart is real-world utility. Remittix is bridging crypto with local payment systems, making cross-border transfers faster, simpler, and cheaper than ever.
UNLOCKING! 🔥 Remittix 🔥 A 2025 MUST-HAVE!
With its flat-fee model, users skip the hidden FX charges and wire fees that banks still love. What you send is exactly what’s received.
Now in presale, Remittix has already attracted over 30,000 investors, raising $15 million. With the token price upto $0.0757, talk of a $1 target is heating up fast.
Conclusion
Pi, Pepe, and Injective have led the market this week with impressive gains, 104%, 73%, and 42%, respectively. These surges show strong momentum and renewed investor interest in both meme coins and serious DeFi projects.
But while the spotlight shines on them now, Remittix (RTX) is quietly stealing the show in the background. Withpresale growth, over 30,000 investors, and a real use case in global payments, Remittix is the one to watch.
https://remittix.io/
https://linktr.ee/remittix
